Wellgistics Health, Inc. announced on May 29, 2025, its preliminary inclusion in the Russell 2000 and Russell 3000 Indexes. This inclusion is part of the 2025 Russell US Indexes annual reconstitution process. FTSE Russell released the preliminary list of additions and deletions on May 23.
Final inclusion in these indexes is expected to take effect following the close of the U.S. equity market on Friday, June 27, 2025. Inclusion in these widely followed indexes can increase the company's visibility among institutional investors. It can also potentially enhance the liquidity of its common stock.
This milestone reflects Wellgistics Health's growing presence as a healthcare infrastructure company. It underscores its efforts to transform the prescription drug ecosystem. The company continues to build its integrated platform for drug distribution and access.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.